During the recent session, BioAge Labs Inc (NASDAQ:BIOA)’s traded shares were 0.41 million. At the last check today, the stock’s price was $5.90, reflecting an intraday gain of 6.12% or $0.34. The 52-week high for the BIOA share is $26.62, that puts it down -351.19 from that peak though still a striking 34.75% gain since the share price plummeted to a 52-week low of $3.85. The company’s market capitalization is $211.51M, and the average intraday trading volume over the past 10 days was 1.55 million shares, and the average trade volume was 747.80K shares over the past three months.

BioAge Labs Inc (NASDAQ:BIOA) trade information

BioAge Labs Inc (BIOA) registered a 6.12% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 6.12% in intraday trading to $5.90, hitting a weekly high. The stock’s 5-day price performance is 0.34%, and it has moved by -65.86% in 30 days. The short interest in BioAge Labs Inc (NASDAQ:BIOA) is 1.35 million shares and it means that shorts have 1.45 day(s) to cover.

The consensus price target of analysts on Wall Street is $40, which implies an increase of 85.25% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $7 and $45 respectively. As a result, BIOA is trading at a discount of -662.71% off the target high and -18.64% off the low.

BIOA Dividends

BioAge Labs Inc is due to release its next quarterly earnings in February. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.